Article

South China Morning PostSouth China Morning Post on 2021-01-22 14:30

Coronavirus mutations pose challenge to vaccine makers

Studies send mixed messages whether the Pfizer-BioNTech vaccine will be able to tackle the variant that emerged in Britain.

Related news